Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'mdma MS' OR with Authors including 'mdma MS' OR with Abstract including 'mdma MS' OR with Keywords including 'mdma MS'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Anderson GM 3d, Braun G, ... Absolute configuration and psychotomimetic activity NIDA Res Monogr 1978
Beardsley PM, Balster RL,... Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus ... Drug Alcohol Depend 1986
Beck J MDMA: The popularization and resultant implications of a recently cont... Contemporary Drug Pr... 1986
Downing J The psychological and physiological effects of MDMA on normal voluntee... J Psychoactive Drugs 1986
Hayner GN, McKinney H MDMA. The dark side of ecstasy J Psychoactive Drugs 1986
Newmeyer JA Some considerations on the prevalence of MDMA use J Psychoactive Drugs 1986
Schmidt CJ, Wu L, Lovenbe... Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine an... Eur J Pharmacol 1986
Shulgin AT The background and chemistry of MDMA J Psychoactive Drugs 1986
Siegel RK MDMA-Nonmedical use and intoxication J Psychoactive Drugs 1986
Stone DM, Stahl DC, Hanso... The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... Eur J Pharmacol 1986
Gibb JW, Stone DM, Stahl ... The effects of amphetamine-like designer drugs on monoaminergic system... NIDA Res Monogr 1987
Mokler DJ, Robinson SE, R... (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... Eur J Pharmacol 1987
Stone DM, Hanson GR, Gibb... Differences in the central serotonergic effects of methylenedioxymetha... Neuropharmacology 1987
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Johnson M, Hanson GR, Gib... Effects of dopaminergic and serotonergic receptor blockade on neuroche... Neuropharmacology 1988
Johnson M, Letter AA, Mer... Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... J Pharmacol Exp Ther 1988
Ruangyuttikarn W, Moody D... Comparison of three commercial amphetamine immunoassays for detection ... J Anal Toxicol 1988
Stone DM, Johnson M, Hans... Role of endogenous dopamine in the central serotonergic deficits induc... J Pharmacol Exp Ther 1988
Wilkerson G, London ED Effects of methylenedioxymethamphetamine on local cerebral glucose uti... Neuropharmacology 1989
Battaglia G, De Souza EB Pharmacologic profile of amphetamine derivatives at various brain reco... NIDA Res Monogr 1989
Dimpfel W, Spuler M, Nich... Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... Psychopharmacology (... 1989
Gold LH, Geyer MA, Koob G... Psychostimulant properties of MDMA NIDA Res Monogr 1989
Gold LH, Geyer MA, Koob G... Neurochemical mechanisms involved in behavioral effects of amphetamine... NIDA Res Monogr 1989
Gold LH, Koob GF MDMA produces stimulant-like conditioned locomotor activity Psychopharmacology (... 1989
Li AA, Marek GJ, Vosmer G... Long-term central 5-HT depletions resulting from repeated administrati... Pharmacol Biochem Be... 1989
Nader MA, Hoffmann SM, Ba... Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-... Psychopharmacology (... 1989
Slikker W Jr, Holson RR, ... Behavioral and neurochemical effects of orally administered MDMA in th... Neurotoxicology 1989
Azmitia EC, Murphy RB, Wh... MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for ... Brain Res 1990
Callaway CW, Wing LL, Gey... Serotonin release contributes to the locomotor stimulant effects of 3,... J Pharmacol Exp Ther 1990
Cody JT Detection of D,L-amphetamine, D,L-methamphetamine, and illicit ampheta... J Anal Toxicol 1990
Cody JT Cross-reactivity of amphetamine analogues with Roche Abuscreen radioim... J Anal Toxicol 1990
Davies JB, Ditton J The 1990s: decade of the stimulants? Br J Addict 1990
De Souza EB, Battaglia G,... Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... Ann N Y Acad Sci 1990
Gibb JW, Johnson M, Hanso... Neurochemical basis of neurotoxicity Neurotoxicology 1990
Hiramatsu M, Cho AK Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... Neuropharmacology 1990
Johnson MP, Huang XM, Obe... Behavioral, biochemical and neurotoxicological actions of the alpha-et... Eur J Pharmacol 1990
Kunsman GW, Manno JE, Coc... Application of the Syva EMIT and Abbott TDx amphetamine immunoassays t... J Anal Toxicol 1990
Nash JF Ketanserin pretreatment attenuates MDMA-induced dopamine release in th... Life Sci 1990
Nichols DE, Oberlender R Structure-activity relationships of MDMA and related compounds: a new ... Ann N Y Acad Sci 1990
Oberlender R, Nichols DE (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... J Pharmacol Exp Ther 1990
Piercey MF, Lum JT, Palme... Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminer... Brain Res 1990
Scheffel U, Ricaurte GA Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... Brain Res 1990
Schmidt CJ, Taylor VL Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by ... Eur J Pharmacol 1990
Yousif MY, Fitzgerald RL,... Identification of metabolites of 3,4-methylenedioxymethamphetamine in ... Drug Alcohol Depend 1990
Greer GR,Tolbert R The Therapeutic Use of MDMA Ecstasy: The clinica... 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Paris JM, Cunningham KA Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... NIDA Res Monogr 1991
Ali SF, Chang LW, Slikker... Biogenic amines as biomarkers for neurotoxicity Biomed Environ Sci 1991
Battaglia G, Sharkey J, K... Neuroanatomic specificity and time course of alterations in rat brain ... Synapse 1991
Fukuto JM, Kumagai Y, Cho... Determination of the mechanism of demethylenation of (methylenedioxy)p... J Med Chem 1991
Gan BK, Baugh D, Liu RH, ... Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methyl... J Forensic Sci 1991
Glennon RA Phenylalkylamine stimulants, hallucinogens, and designer drugs NIDA Res Monogr 1991
Hiramatsu M, DiStefano E,... A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effect... Eur J Pharmacol 1991
Johnson M, Bush LG, Gibb ... Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... Eur J Pharmacol 1991
Johnson MP, Huang XM, Nic... Serotonin neurotoxicity in rats after combined treatment with a dopami... Pharmacol Biochem Be... 1991
Kumagai Y, Lin LY, Schmit... Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl co... Chem Res Toxicol 1991
Millan MJ, Colpaert FC Methylenedioxymethamphetamine induces spontaneous tail-flicks in the r... Eur J Pharmacol 1991
Fukuto JM, Kumagai Y, Cho... Determination of the mechanism of demethylenation of (methylenedioxy)p... J Med Chem 1991
Henry JA, Jeffreys KJ, Da... Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy') Lancet 1992
Gouzoulis E, Steiger A, E... Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in ... Biol Psychiatry 1992
Callaway CW, Rempel N, Pe... Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced b... Neuropsychopharmacol... 1992
Elayan I, Gibb JW, Hanson... Long-term alteration in the central monoaminergic systems of the rat b... Eur J Pharmacol 1992
Grob CS, Bravo GL, Walsh ... The MDMA-neurotoxicity controversy: implications for clinical research... J Nerv Ment Dis 1992
Helmlin HJ, Brenneisen R Determination of psychotropic phenylalkylamine derivatives in biologic... J Chromatogr 1992
Henry JA Ecstasy and the dance of death BMJ 1992
Herndon JL, Pierson ME, G... Mechanistic investigation of the stimulus properties of 1-(3-trifluoro... Pharmacol Biochem Be... 1992
Huang X, Marona-Lewicka D... p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Relea... Eur J Pharmacol 1992
Johnson M, Elayan I, Hans... Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... J Pharmacol Exp Ther 1992
Lehmann J, DeSouza EB, Cu... Regional distribution to recovery of 5-HT levels after administration ... Ann N Y Acad Sci 1992
Liester MB, Grob CS, Brav... Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use J Nerv Ment Dis 1992
Paris JM, Cunningham KA Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... Brain Res Bull 1992
Ricaurte GA, McCann UD Neurotoxic amphetamine analogues: effects in monkeys and implications ... Ann N Y Acad Sci 1992
Solowij N, Hall W, Lee N Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and thei... Br J Addict 1992
Thurman EM, Pedersen MJ, ... Distinguishing sympathomimetic amines from amphetamine and methampheta... J Anal Toxicol 1992
Huang X, Marona-Lewicka D... p-methylthioamphetamine is a potent new non-neurotoxic serotonin-relea... Eur J Pharmacol 1992
Heilig, Steve MDMA Update: The Science and Politics of Ecstasy Newsletter of the Ca... 1993
Stolaroff MJ, Wells CW Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7 Yearbook for Ethnome... 1993
Wodarz N 'Ecstasy'-induced psychotic depersonalization syndrome Nervenarzt 1993
Allen RP, McCann UD, Rica... Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... Sleep 1993
Cregg MT, Tracey JA Ecstasy abuse in Ireland Ir Med J 1993
McCann UD, Ricaurte GA Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... J Clin Psychopharmac... 1993
Ricaurte GA, Markowska AL... 3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... J Pharmacol Exp Ther 1993
Rudnick G, Wall SC Non-neurotoxic Amphetamine Derivatives Release Serotonin through Serot... Mol Pharmacol 1993
Schuldiner S, Steiner-Mor... Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... Mol Pharmacol 1993
Cassidy G, Ballard CG Psychiatric sequelae of MDMA (ecstasy) and related drugs Irish Journal of Psy... 1994
Hooft PJ, van de Voorde H... Reckless behaviour related to the use of 3,4-methylenedioxymethampheta... Int J Legal Med 1994
Kramer K, Azmitia EC, Whi... In vitro release of [3H]5-hydroxytryptamine from fetal and maternal br... Brain Res Dev Brain ... 1994
McCann UD, Ridenour A, Sh... Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... Neuropsychopharmacol... 1994
McGuire PK, Cope H, Fahy ... Diversity of psychopathology associated with use of 3,4-methylenedioxy... Br J Psychiatry 1994
O'Callaghan JP, Miller DB Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... J Pharmacol Exp Ther 1994
Snape MF, Colado MI, et a... Chlormethiazole and dizocilpine block the behavioural, but not the neu... Pharmacol Toxicol 1994
Ward C, McNally AJ, Rusyn... 125I radioimmunoassay for the dual detection of amphetamine and metham... J Forensic Sci 1994
Harlow D, Galloway G, Jes... Raves and Drug Use: An Exploratory Study Botec Analysis 1994
McDermott P MDMA Use in the North West of England International Journa... 1994
Heilig,S Book Review: Pursuit of Ecstasy: The MDMA Experience by Beck, J & Rose... Journal of Psychoact... 1994
Cadet JL, Ladenheim B, Hi... Superoxide radicals mediate the biochemical effects of methylenedioxym... Synapse 1995
Campbell DB The use of toxicokinetics for the safety assessment of drugs acting in... Mol Neurobiol 1995
Cerruti C, Sheng P, Laden... Involvement of oxidative and L-arginine-NO pathways in the neurotoxici... Clin Exp Pharmacol P... 1995
Cirimele V, Kintz P, Mang... Detection of amphetamines in fingernails: an alternative to hair analy... Arch Toxicol 1995
Wichems CH, Hollingsworth... Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... Brain Res 1995

Page 1 of 6   /   520 Entries Returned
2 3 4 5 6 next